AZ preps for UK distribution switch

AstraZeneca is plowing ahead with a new distribution deal in the UK, despite opposition from regulators there. According to a letter sent to community pharmacists yesterday, AstraZeneca will start the new distribution scheme--handled through just two partners, AAH Pharmaceuticals and UniChem--on February 2.

Under the deal, different drugs will get different discounts off their retail prices, and those discounts won't change with volume. Pharmacies might qualify for rebates, though, according to the total amount of AstraZeneca products they buy each month.

Health officials fear that the direct distribution arrangement--similar to Pfizer's deal with just one distributor, Unichem--will push wholesale prices of certain drugs above National Health Service reimbursement levels. Last week, the country's Office of Fair Trading issued a negative report on the distribution deals and urged the NHS to revise its pricing arrangements to keep costs from rising.

- see the report from Medical News Today
- read this article for more

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.